History of the Former Yamanouchi Pharmaceutical Co., Ltd.
Changed the name to Yamanouchi Pharmaceutical Co., Ltd. in 1940, Moves the head office to Tokyo in 1942
Currently sold in more than 100 countries
The first overseas production base for active pharmaceutical ingredients
Currently sold in more than 90 countries
Sales base of the company in the U.S.
Launched in the U.S. as well in 2005
OTC businesses of both companies were integrated in October 1, 2004 to form Zepharma Inc.
History of the Former Fujisawa Pharmaceutical Co., Ltd.
Proceeds to market it worldwide.
The company's first business base in the U.S.
Currently sold in about 100 countries
Currently sold in about 60 countries
History of Astellas Pharma Inc.
Sold Zephama shared to Daiichi Sankyo Co., Ltd.
Launched Kiklin® Capsules in Japan for the treatment for Hyperphosphatemia
Launched Myrbetriq® (mirabegron) in the U.S. for the treatment of overactive bladder (OAB)